{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:19:11Z","timestamp":1791433151960,"version":"4.3.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,4,9]],"date-time":"2009-04-09T00:00:00Z","timestamp":1239235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,4,9]],"date-time":"2009-04-09T00:00:00Z","timestamp":1239235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1038\/leu.2009.75","type":"journal-article","created":{"date-parts":[[2009,4,9]],"date-time":"2009-04-09T09:43:47Z","timestamp":1239270227000},"page":"1374-1377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"23","author":[{"given":"P J","family":"Real","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,9]]},"reference":[{"key":"BFleu200975_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0037-1963(00)90018-0","volume":"37","author":"AA Ferrando","year":"2000","unstructured":"Ferrando AA, Look AT . Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol 2000; 37: 381\u2013395.","journal-title":"Semin Hematol"},{"key":"BFleu200975_CR2","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535\u20131548.","journal-title":"N Engl J Med"},{"key":"BFleu200975_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(95)90164-7","volume":"345","author":"JM Chessells","year":"1995","unstructured":"Chessells JM, Bailey C, Richards SM . Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet 1995; 345: 143\u2013148.","journal-title":"Lancet"},{"key":"BFleu200975_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"CH Pui","year":"1998","unstructured":"Pui CH, Evans WE . Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605\u2013615.","journal-title":"N Engl J Med"},{"key":"BFleu200975_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0140-6736(91)90733-6","volume":"337","author":"GK Rivera","year":"1991","unstructured":"Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M et al. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61\u201366.","journal-title":"Lancet"},{"key":"BFleu200975_CR6","first-page":"3310","volume":"95","author":"M Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000; 95: 3310\u20133322.","journal-title":"Blood"},{"key":"BFleu200975_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","volume":"97","author":"LB Silverman","year":"2001","unstructured":"Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 2001; 97: 1211\u20131218.","journal-title":"Blood"},{"key":"BFleu200975_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1182\/blood-2006-07-038299","volume":"110","author":"JB Nachman","year":"2007","unstructured":"Nachman JB, Heerema NA, Sather H, Camitta B, Forestier E, Harrison CJ et al. Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood 2007; 110: 1112\u20131115.","journal-title":"Blood"},{"key":"BFleu200975_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","volume":"109","author":"AK Fielding","year":"2007","unstructured":"Fielding AK, Richards SM, Chopra R, Lazarus HM, Litzow MR, Buck G et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12\/ECOG 2993 study. Blood 2007; 109: 944\u2013950.","journal-title":"Blood"},{"key":"BFleu200975_CR10","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1182\/blood-2008-07-168625","volume":"113","author":"JJ Cornelissen","year":"2009","unstructured":"Cornelissen JJ, van der Holt B, Verhoef GE, van\u2019t Veer MB, van Oers MH, Schouten HC et al. Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood 2009; 113: 1375\u20131382.","journal-title":"Blood"},{"key":"BFleu200975_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11912-008-0070-3","volume":"10","author":"TM Harned","year":"2008","unstructured":"Harned TM, Gaynon P . Relapsed acute lymphoblastic leukemia: current status and future opportunities. Curr Oncol Rep 2008; 10: 453\u2013458.","journal-title":"Curr Oncol Rep"},{"key":"BFleu200975_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269\u2013271.","journal-title":"Science"},{"key":"BFleu200975_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1182\/blood-2007-12-130096","volume":"112","author":"ML Sulis","year":"2008","unstructured":"Sulis ML, Williams O, Palomero T, Tosello V, Pallikuppam S, Real PJ et al. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. Blood 2008; 112: 733\u2013740.","journal-title":"Blood"},{"key":"BFleu200975_CR14","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1084\/jem.20070872","volume":"204","author":"BJ Thompson","year":"2007","unstructured":"Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 2007; 204: 1825\u20131835.","journal-title":"J Exp Med"},{"key":"BFleu200975_CR15","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/sj.leu.2403896","volume":"19","author":"SY Lee","year":"2005","unstructured":"Lee SY, Kumano K, Masuda S, Hangaishi A, Takita J, Nakazaki K et al. Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children. Leukemia 2005; 19: 1841\u20131843.","journal-title":"Leukemia"},{"key":"BFleu200975_CR16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1182\/blood-2005-12-4956","volume":"108","author":"S Breit","year":"2006","unstructured":"Breit S, Stanulla M, Flohr T, Schrappe M, Ludwig WD, Tolle G et al. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 2006; 108: 1151\u20131157.","journal-title":"Blood"},{"key":"BFleu200975_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1097-2765(00)80417-7","volume":"5","author":"C Brou","year":"2000","unstructured":"Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 2000; 5: 207\u2013216.","journal-title":"Mol Cell"},{"key":"BFleu200975_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S1097-2765(00)80416-5","volume":"5","author":"JS Mumm","year":"2000","unstructured":"Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ et al. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 2000; 5: 197\u2013206.","journal-title":"Mol Cell"},{"key":"BFleu200975_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/toxsci\/kfh254","volume":"82","author":"J Milano","year":"2004","unstructured":"Milano J, McKay J, Dagenais C, Foster-Brown L, Pognan F, Gadient R et al. Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol Sci 2004; 82: 341\u2013358.","journal-title":"Toxicol Sci"},{"key":"BFleu200975_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nature03659","volume":"435","author":"JH van Es","year":"2005","unstructured":"van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H et al. Notch\/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435: 959\u2013963.","journal-title":"Nature"},{"key":"BFleu200975_CR21","doi-asserted-by":"publisher","first-page":"12876","DOI":"10.1074\/jbc.M311652200","volume":"279","author":"GT Wong","year":"2004","unstructured":"Wong GT, Manfra D, Poulet FM, Zhang Q, Josien H, Bara T et al. Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 2004; 279: 12876\u201312882.","journal-title":"J Biol Chem"},{"key":"BFleu200975_CR22","doi-asserted-by":"publisher","first-page":"46107","DOI":"10.1074\/jbc.M307757200","volume":"278","author":"GH Searfoss","year":"2003","unstructured":"Searfoss GH, Jordan WH, Calligaro DO, Galbreath EJ, Schirtzinger LM, Berridge BR et al. Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor. J Biol Chem 2003; 278: 46107\u201346116.","journal-title":"J Biol Chem"},{"key":"BFleu200975_CR23","first-page":"6585","volume":"24","author":"D Deangelo","year":"2006","unstructured":"Deangelo D, Stone R, Silverman L, Stock W, Attar E, Fearen I et al. A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia\/lymphoma (T-ALL) and other leukemias. J Clin Oncol 2006 ASCO Annu Meet Proc Part I 2006; 24: 6585.","journal-title":"J Clin Oncol 2006 ASCO Annu Meet Proc Part I"},{"key":"BFleu200975_CR24","doi-asserted-by":"publisher","first-page":"18261","DOI":"10.1073\/pnas.0606108103","volume":"103","author":"T Palomero","year":"2006","unstructured":"Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006; 103: 18261\u201318266.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu200975_CR25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1636","volume":"13","author":"T Palomero","year":"2007","unstructured":"Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13: 1203\u20131210.","journal-title":"Nat Med"},{"key":"BFleu200975_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1073\/pnas.0806445106","volume":"106","author":"AA Margolin","year":"2009","unstructured":"Margolin AA, Palomero T, Sumazin P, Califano A, Ferrando AA, Stolovitzky G . ChIP-on-chip significance analysis reveals large-scale binding and regulation by human transcription factor oncogenes. Proc Natl Acad Sci USA 2009; 106: 244\u2013249.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu200975_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nm.1900","volume":"15","author":"PJ Real","year":"2009","unstructured":"Real PJ, Tosello V, Palomero T, Castillo M, Hernando E, de Stanchina E et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 2009; 15: 50\u201358.","journal-title":"Nat Med"},{"key":"BFleu200975_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.leu.2402733","volume":"17","author":"WJ Tissing","year":"2003","unstructured":"Tissing WJ, Meijerink JP, den Boer ML, Pieters R . Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 2003; 17: 17\u201325.","journal-title":"Leukemia"},{"key":"BFleu200975_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/10428199409056282","volume":"13","author":"GJ Kaspers","year":"1994","unstructured":"Kaspers GJ, Pieters R, Klumper E, De Waal FC, Veerman AJ . Glucocorticoid resistance in childhood leukemia. Leuk Lymphoma 1994; 13: 187\u2013201.","journal-title":"Leuk Lymphoma"},{"key":"BFleu200975_CR30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","volume":"94","author":"M Dordelmann","year":"1999","unstructured":"Dordelmann M, Reiter A, Borkhardt A, Ludwig WD, Gotz N, Viehmann S et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999; 94: 1209\u20131217.","journal-title":"Blood"},{"key":"BFleu200975_CR31","first-page":"2730","volume":"92","author":"M Schrappe","year":"1998","unstructured":"Schrappe M, Arico M, Harbott J, Biondi A, Zimmermann M, Conter V et al. Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood 1998; 92: 2730\u20132741.","journal-title":"Blood"},{"key":"BFleu200975_CR32","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood.V86.10.3861.bloodjournal86103861","volume":"86","author":"E Klumper","year":"1995","unstructured":"Klumper E, Pieters R, Veerman AJ, Huismans DR, Loonen AH, Hahlen K et al. In vitro cellular drug resistance in children with relapsed\/refractory acute lymphoblastic leukemia. Blood 1995; 86: 3861\u20133868.","journal-title":"Blood"},{"key":"BFleu200975_CR33","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1182\/blood.V89.8.2959","volume":"89","author":"T Hongo","year":"1997","unstructured":"Hongo T, Yajima S, Sakurai M, Horikoshi Y, Hanada R . In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood 1997; 89: 2959\u20132965.","journal-title":"Blood"},{"key":"BFleu200975_CR34","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ejca.2005.02.026","volume":"41","author":"GJ Kaspers","year":"2005","unstructured":"Kaspers GJ, Wijnands JJ, Hartmann R, Huismans L, Loonen AH, Stackelberg A et al. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia. Eur J Cancer 2005; 41: 1300\u20131303.","journal-title":"Eur J Cancer"},{"key":"BFleu200975_CR35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.pathmechdis.3.121806.154300","volume":"3","author":"JC Aster","year":"2008","unstructured":"Aster JC, Pear WS, Blacklow SC . Notch Signaling in Leukemia. Annu Rev Pathol 2008; 3: 587\u2013613.","journal-title":"Annu Rev Pathol"},{"key":"BFleu200975_CR36","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S1074-7613(00)80643-3","volume":"9","author":"ML Deftos","year":"1998","unstructured":"Deftos ML, He YW, Ojala EW, Bevan MJ . Correlating notch signaling with thymocyte maturation. Immunity 1998; 9: 777\u2013786.","journal-title":"Immunity"},{"key":"BFleu200975_CR37","doi-asserted-by":"crossref","first-page":"12044","DOI":"10.1016\/S0021-9258(18)37890-6","volume":"263","author":"LP Eisen","year":"1988","unstructured":"Eisen LP, Elsasser MS, Harmon JM . Positive regulation of the glucocorticoid receptor in human T-cells sensitive to the cytolytic effects of glucocorticoids. J Biol Chem 1988; 263: 12044\u201312048.","journal-title":"J Biol Chem"},{"key":"BFleu200975_CR38","first-page":"1378","volume":"59","author":"J Ramdas","year":"1999","unstructured":"Ramdas J, Liu W, Harmon JM . Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. Cancer Res 1999; 59: 1378\u20131385.","journal-title":"Cancer Res"},{"key":"BFleu200975_CR39","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0145-2126(85)90069-4","volume":"9","author":"EG Levine","year":"1985","unstructured":"Levine EG, Peterson BA, Smith KA, Hurd DD, Bloomfield CD . Glucocorticoid receptors in chronic lymphocytic leukemia. Leuk Res 1985; 9: 993\u2013999.","journal-title":"Leuk Res"},{"issue":"11 Part 2","key":"BFleu200975_CR40","first-page":"4861","volume":"41","author":"BG Leventhal","year":"1981","unstructured":"Leventhal BG . Glucocorticoid receptors in lymphoid tumors. Cancer Res 1981; 41 (11 Part 2): 4861\u20134862.","journal-title":"Cancer Res"},{"key":"BFleu200975_CR41","doi-asserted-by":"publisher","first-page":"10978","DOI":"10.1021\/bi034651u","volume":"42","author":"KB Pedersen","year":"2003","unstructured":"Pedersen KB, Vedeckis WV . Quantification and glucocorticoid regulation of glucocorticoid receptor transcripts in two human leukemic cell lines. Biochemistry 2003; 42: 10978\u201310990.","journal-title":"Biochemistry"},{"key":"BFleu200975_CR42","doi-asserted-by":"publisher","first-page":"10851","DOI":"10.1021\/bi049458u","volume":"43","author":"KB Pedersen","year":"2004","unstructured":"Pedersen KB, Geng CD, Vedeckis WV . Three mechanisms are involved in glucocorticoid receptor autoregulation in a human T-lymphoblast cell line. Biochemistry 2004; 43: 10851\u201310858.","journal-title":"Biochemistry"},{"key":"BFleu200975_CR43","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1242\/dev.129.11.2619","volume":"129","author":"JP Katz","year":"2002","unstructured":"Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002; 129: 2619\u20132628.","journal-title":"Development"},{"key":"BFleu200975_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/carcin\/bgi243","volume":"27","author":"D Wei","year":"2006","unstructured":"Wei D, Kanai M, Huang S, Xie K . Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 2006; 27: 23\u201331.","journal-title":"Carcinogenesis"},{"key":"BFleu200975_CR45","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1182\/blood-2006-01-0261","volume":"108","author":"WJ Tissing","year":"2006","unstructured":"Tissing WJ, Meijerink JP, Brinkhof B, Broekhuis MJ, Menezes RX, den Boer ML et al. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL. Blood 2006; 108: 1045\u20131049.","journal-title":"Blood"},{"key":"BFleu200975_CR46","doi-asserted-by":"crossref","unstructured":"Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K et al. NOTCH1\/FBXW7 mutation identifies a large subgroup with favourable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a GRAALL study. Blood 2008, 23 December 2008 [E-pub ahead of print].","DOI":"10.1182\/blood.V112.11.1494.1494"},{"key":"BFleu200975_CR47","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-05-3054","volume":"66","author":"S Stylianou","year":"2006","unstructured":"Stylianou S, Clarke RB, Brennan K . Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006; 66: 1517\u20131525.","journal-title":"Cancer Res"},{"key":"BFleu200975_CR48","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1158\/0008-5472.CAN-04-1890","volume":"65","author":"BW Purow","year":"2005","unstructured":"Purow BW, Haque RM, Noel MW, Su Q, Burdick MJ, Lee J et al. Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res 2005; 65: 2353\u20132363.","journal-title":"Cancer Res"},{"key":"BFleu200975_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.semcancer.2004.04.016","volume":"14","author":"S Pahlman","year":"2004","unstructured":"Pahlman S, Stockhausen MT, Fredlund E, Axelson H . Notch signaling in neuroblastoma. Semin Cancer Biol 2004; 14: 365\u2013373.","journal-title":"Semin Cancer Biol"},{"key":"BFleu200975_CR50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1349-7006.2006.00369.x","volume":"98","author":"K Kimura","year":"2007","unstructured":"Kimura K, Satoh K, Kanno A, Hamada S, Hirota M, Endoh M et al. Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice. Cancer Sci 2007; 98: 155\u2013162.","journal-title":"Cancer Sci"},{"key":"BFleu200975_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1158\/1535-7163.MCT-05-0299","volume":"5","author":"Z Wang","year":"2006","unstructured":"Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH . Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006; 5: 483\u2013493.","journal-title":"Mol Cancer Ther"},{"key":"BFleu200975_CR52","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1158\/0008-5472.CAN-07-1022","volume":"67","author":"J Konishi","year":"2007","unstructured":"Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP et al. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res 2007; 67: 8051\u20138057.","journal-title":"Cancer Res"},{"key":"BFleu200975_CR53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.devcel.2009.01.015","volume":"16","author":"LK Phng","year":"2009","unstructured":"Phng LK, Gerhardt H . Angiogenesis: A Team Effort Coordinated by Notch. Dev Cell 2009; 16: 196\u2013208.","journal-title":"Dev Cell"},{"key":"BFleu200975_CR54","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.bjc.6604484","volume":"99","author":"G Thurston","year":"2008","unstructured":"Thurston G, Kitajewski J . VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. Br J Cancer 2008; 99: 1204\u20131209.","journal-title":"Br J Cancer"},{"key":"BFleu200975_CR55","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1038\/onc.2008.227","volume":"27","author":"J Dufraine","year":"2008","unstructured":"Dufraine J, Funahashi Y, Kitajewski J . Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 2008; 27: 5132\u20135137.","journal-title":"Oncogene"},{"key":"BFleu200975_CR56","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.1158\/0008-5472.CAN-07-0969","volume":"67","author":"JL Li","year":"2007","unstructured":"Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Res 2007; 67: 11244\u201311253.","journal-title":"Cancer Res"},{"key":"BFleu200975_CR57","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nature05313","volume":"444","author":"J Ridgway","year":"2006","unstructured":"Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 2006; 444: 1083\u20131087.","journal-title":"Nature"},{"key":"BFleu200975_CR58","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature05355","volume":"444","author":"I Noguera-Troise","year":"2006","unstructured":"Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006; 444: 1032\u20131037.","journal-title":"Nature"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu200975.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200975","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200975.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:26:05Z","timestamp":1648729565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu200975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,9]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["BFleu200975"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.75","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,9]]},"assertion":[{"value":"18 February 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}